Supernus Pharmaceuticals Inc (SUPN.OQ)

SUPN.OQ on NASDAQ Stock Exchange Global Market

8.19USD
4:00pm EDT
Price Change (% chg)

$-0.22 (-2.62%)
Prev Close
$8.41
Open
$8.43
Day's High
$8.47
Day's Low
$8.15
Volume
207,198
Avg. Vol
139,565
52-wk High
$11.45
52-wk Low
$5.84

SUPN.OQ

Chart for SUPN.OQ

About

Supernus Pharmaceuticals, Inc. (Supernus) is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Supernus is developing several product candidates in neurology and psychiatry to address... (more)

Overall

Beta: --
Market Cap (Mil.): $360.97
Shares Outstanding (Mil.): 42.92
Dividend: --
Yield (%): --

Financials

  SUPN.OQ Industry Sector
P/E (TTM): -- 32.70 33.56
EPS (TTM): -1.72 -- --
ROI: -61.63 18.13 17.36
ROE: -169.92 18.84 18.23
Search Stocks

Competitors

  Price Change
Abbott Laboratories (ABT.N) $43.59 -0.10
AstraZeneca plc (AZN.L) 4,578.50p +42.00
Eli Lilly and Co (LLY.N) $66.53 -0.06
Shire PLC (SHP.L) 5,290.00p -30.00
Shire PLC (3159084.L) -- --
Smiths Group plc (SMIN.L) 1,307.00p +7.00

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Zacks Investment Research Inc.
$12.00
Provider: Ford Investor Services, Inc.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks